Passage BIO, Inc. (PASG) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $46.30M | +23.2% |
| 2024 | $37.57M | +73.1% |
| 2023 | $21.71M | -37.3% |
| 2022 | $34.60M | -73.2% |
| 2021 | $128.97M | -4.5% |
| 2020 | $135.00M | -15.0% |
| 2019 | $158.87M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $46.30M | +23.2% |
| 2024 | $37.57M | +73.1% |
| 2023 | $21.71M | -37.3% |
| 2022 | $34.60M | -73.2% |
| 2021 | $128.97M | -4.5% |
| 2020 | $135.00M | -15.0% |
| 2019 | $158.87M | — |